VALLON PHARMACEUTICALS INC's ticker is VLON and the CUSIP is 92023M101. A total of 12 filers reported holding VALLON PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $380,000 | -67.9% | 201,758 | +1.9% | 0.05% | -71.6% |
| Q4 2021 | $1,184,000 | -17.8% | 198,085 | 0.0% | 0.18% | +74.3% |
| Q3 2021 | $1,440,000 | +89.2% | 198,085 | +41.5% | 0.10% | +62.9% |
| Q2 2021 | $761,000 | +17.3% | 140,000 | 0.0% | 0.06% | +181.8% |
| Q1 2021 | $649,000 | – | 140,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WELLS FARGO & COMPANY/MN | 15 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 21,569 | $13,000 | 0.00% |
| CITIGROUP INC | 6,000 | $4,000 | 0.00% |
| North Star Investment Management Corp. | 1,750 | $1,000 | 0.00% |
| MORGAN STANLEY | 50 | $0 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 35,798 | $23,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 12,040 | $8,000 | 0.00% |
| Renaissance Technologies | 78,888 | $50,000 | 0.00% |
| VANGUARD GROUP INC | 23,464 | $15,000 | 0.00% |